JD Health InternationalJDHIF 90 ROC (Joel Greenblatt) % is 583.29% as of Dec. 2025, which is 1230% above its 10-year median of 43.85. GuruFocus rates JDHIF with a GF Score™ of 90/100 and a GF Value™ of $9.27. The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, JD Health International ranks better than 98.5% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. JD Health International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 583.29%.
The historical rank and industry rank for JD Health International's ROC (Joel Greenblatt) % or its related term are showing as below:
JDHIF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -26217.43 Med: 43.85 Max: 614.84
Current: 609.03
During the past 9 years, JD Health International's highest ROC (Joel Greenblatt) % was 614.84%. The lowest was -26217.43%. And the median was 43.85%.
JDHIF's ROC (Joel Greenblatt) % is ranked better than 98.5% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 12.485
vs JDHIF: 609.03
JD Health International's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
JD Health International (OTCPK:JDHIF) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
JD Health International ROC (Joel Greenblatt) % Related Terms
JD Health International ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for JD Health International's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JD Health International ROC (Joel Greenblatt) % Chart
JD Health International ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, JD Health International's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JD Health International ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where JD Health International's ROC (Joel Greenblatt) % falls into.
JD Health International ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 583.29% mean?
JD Health International (JDHIF) has a ROC (Joel Greenblatt) % of 583.29% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on JD Health International and its competitors. This is 1230% above median its historical median of 43.85. According to the industry distribution chart, JD Health International ranks #10 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 1.5%.
Is JD Health International's ROC (Joel Greenblatt) % too high?
JD Health International's current ROC (Joel Greenblatt) % of 583.29% is 1230% above median its 10-year median of 43.85. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. JD Health International's value of 583.29% is 4571.9% above this industry median. Based on the distribution chart, JD Health International ranks #10 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, JD Health International has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does JD Health International's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, JD Health International ranks #10 out of 668 companies for ROC (Joel Greenblatt) %. This places JD Health International in the top 2% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.49. JD Health International's value of 583.29% is 4571.9% above this benchmark. While the company's 10-year median is 43.85 vs. the industry median of 12.49, JD Health International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JD Health International's current ROC (Joel Greenblatt) % of 583.29% is 4571.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on JD Health International and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JD Health International's current ROC (Joel Greenblatt) % is 583.29%, which is 1230% above median its own 10-year median of 43.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JD Health International stock overvalued right now?
JD Health International (JDHIF) has a current ROC (Joel Greenblatt) % of 583.29%. The stock's GF Value™ is $9.27, compared to a current price of $5.85 — trading 36.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 583.29%, which is 1230% above median its 10-year median of 43.85 and 4571.9% above the Healthcare Providers & Services industry median of 12.49. JD Health International's overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For JD Health International (JDHIF), the current ROC (Joel Greenblatt) % is 583.29% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JD Health International (JDHIF) Overvalued in 2026?
Based on GuruFocus' analysis, JD Health International stock appears to be undervalued.
The current stock price of $5.85 is trading 36.9% below its estimated GF Value™ of $9.27.
Key valuation signals for JDHIF:
ROC (Joel Greenblatt) %: 583.29% (1230% above median its 10-year median of 43.85)
GF Value™: $9.27 vs. price of $5.85 (36.9% below fair value)
Industry Position: 4571.9% above the Healthcare Providers & Services median (#10 of 668)
No single metric tells the full story. See the JDHIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health and Meituan for its e-commerce business. As of Dec. 31, 2024, the platform has over 200 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.
90GF Score
Get the complete analysis for JDHIF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JDHIF has been successfully added to your 
